|
Dr. Curd became the President and CMO in October 2007. Dr. Curd joins Threshold as a member of the management team and will lead the clinical development of the Company’s product development candidates and help to identify additional opportunities for Threshold. Dr. Curd joins Threshold from Novacea Inc. where he was the president and chief medical officer since 2001. From May 2001 to December 2001 Dr. Curd served as senior vice president of Development and interim president for Vaccines at Maxygen Inc. From June 1999 to May 2001 Dr. Curd served as executive vice president at VaxGen Inc. From December 1991 to June 1999 Dr. Curd served in various positions including vice president of Clinical Development at Genentech Inc. While at Genentech he directed the clinical development of Herceptin® Rituxan® Xolair® and Raptiva®. From 1978 to 1991 Dr. Curd served in various positions including president of the Medical Staff at Scripps Clinical and Research Foundation La Jolla California. Dr. Curd holds a B.S. in chemistry from Princeton University and an M.D. from Harvard Medical School. | 